This Title All WIREs
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 9.182

The need to pursue and publish clinical trials in nanomedicine

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies

Related Articles

The NCI Alliance for Nanotechnology in Cancer: achievement and path forward
Nanoparticle therapeutics: a personal perspective
Sample size calculations for clinical trials (WIREs WIREs Computational Statistics )

Browse by Topic

Therapeutic Approaches and Drug Discovery > Emerging Technologies

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts